Session: Supercharging the Clinical Trial Process Through the Power of AI
With the rapid increase of global pandemics, epidemics and developing nations needing more assistance with healthcare and pharmaceuticals, the Life Sciences Industry is at a pivotal moment in time where the advancements in artificial intelligence (AI) can help to speed up the time it takes for drugs to get to market while reducing cost and mitigating risk. Due to newly passed legislation to reduce the cost of pharmaceuticals and the immediate need for vaccines and pharmaceuticals the world experienced during the COVID-19 Pandemic, AI is now the most prominent disruptor of the Life Sciences Industry.
Bio
With 20 years of experience in media, tech, marketing and public relations, Jennifer brings a wealth of knowledge, skills and leadership helping brands grow to their highest potential utilizing her experience with digital marketing, demand generation, data reporting and brand development. She is currently serving as President of Narrativa, one of the fastest growing international AI technology companies in the world, forging the path to bring artificial intelligence automation to multiple industries, including Life Sciences, Finance, MarTech, Gaming and AEC.
Throughout her career, she specialized as a multi-faceted VP of Marketing and Branded Content Specialist serving many clients, including: ExxonMobil, Chevron, Entertainment Tonight, Dr. Phil, Cesar Millan, TBS, Hulu, Beliefnet, OWN, San Francisco Giants and more.